GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
155
c/trialwatch·posted 1 year ago by u/valeria_karlsen

[Discussion] the SURPASS advice in here is 8 years out of date

Discussion

Right, the TRIUMPH question again, but with numbers this time.

I have 14 data points over 40 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.

The thing I would flag for anyone new: the effect I am describing showed up at week 63, not week 17. People give up long before the interesting part.

Interested in whether this matches other people's logs or whether I am an outlier.

163 up / 8 down95% upvoted21 commentsid 10bs6s29 Sep 2024

21 comments

14 in this archive, depth 3

best — the order this archive was captured in

u/injection_site_iris23 points·1 year ago

the relative risk reduction in headlines is not the whole story

replysharereportpermalink
[deleted]8 points·1 year ago

[deleted]

replysharereportpermalink
u/whois_wanda2 points·1 year ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/nightowl_injector14 points·1 year ago

This is correct. Discontinuation arms show the regain reality.

replysharereportpermalink
u/valeria_karlsenOP9 points·1 year ago

Phase 2 TRIUMPH looked amazing. Phase 3 trials are harder. Do not anchor on phase 2 readouts.

replysharereportpermalink
u/hamza_zielinski7 points·1 year ago

Yeah, absolute numbers matter more than the press release.

replysharereportpermalink
load more comments (1) →
u/ines_castellanos11 points·1 year ago

Half-life is about 168 hours, so steady state lands around week 14–5. Practical consequence: what you feel in week 1 is not what that dose does.

replysharereportpermalink
u/whois_wanda7 points·1 year ago

Is that absolute or relative risk reduction?

replysharereportpermalink
u/plateau_patrol9 points·1 year ago·edited

number-needed-to-treat is the house dialect

replysharereportpermalink
u/whois_wanda6 points·1 year ago

phase 2 is not phase 3, smaller n and shorter trial

replysharereportpermalink
u/hamza_zielinski4 points·1 year ago

give the trial name, phase, n, and primary endpoint in the body

replysharereportpermalink
u/valeria_karlsen3 points·1 year ago

The confident tone is doing a lot of work that the evidence is not.

replysharereportpermalink
load more comments (1) →
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/trialwatch

Clinical trial reading group. New readouts, protocol amendments, endpoint definitions, dropout handling, and the difference between a press release and a publication. Absolute risk reduction and number-needed-to-treat are house dialect here.

34kmembers
95submissions
Nov 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/trialwatch rules
  1. Press-release-only posts must be flaired Press Release until a publication exists.
  2. Give the trial name, phase, n, and primary endpoint in the body.
  3. Relative risk reduction alone is not a result. Show the absolute numbers.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.